Cargando…

Combined clinical features and MRI parameters for the prediction of VEGFR2 in hepatocellular carcinoma patients

PURPOSE: To develop a prediction model for estimating the expression of vascular endothelial growth factor receptor 2 (VEGFR2) in hepatocellular carcinoma (HCC) patients using clinical features and the contrast-enhanced MRI Liver Imaging Reporting and Data System (LI-RADS). METHODS: A total of 206 H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Laizhu, Cheng, Chunxiao, Li, Binghua, Chen, Jun, Peng, Jin, Cao, Yajuan, Yue, Yang, Mai, Xiaoli, Yu, Decai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608502/ https://www.ncbi.nlm.nih.gov/pubmed/36313714 http://dx.doi.org/10.3389/fonc.2022.961530

Ejemplares similares

Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study
por: Zhang, Laizhu, et al.
Publicado: (2023)

Pan-Cancer Analysis of Glycolytic and Ketone Bodies Metabolic Genes: Implications for Response to Ketogenic Dietary Therapy
por: Qian, Liyuan, et al.
Publicado: (2021)

A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma
por: Song, Yan, et al.
Publicado: (2023)

Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
por: Li, Binghua, et al.
Publicado: (2017)

MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Zhang, Hongbin, et al.
Publicado: (2021)

Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma
por: Liu, Peijun, et al.
Publicado: (2023)

Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma
por: Yan, Jing, et al.
Publicado: (2020)

Three-Dimensional Radiomics Features From Multi-Parameter MRI Combined With Clinical Characteristics Predict Postoperative Cerebral Edema Exacerbation in Patients With Meningioma
por: Xiao, Bing, et al.
Publicado: (2021)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators
por: Chen, Yanling, et al.
Publicado: (2022)

Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma
por: Qiu, Ganbin, et al.
Publicado: (2023)

Comparison of MRI Features of Epithelioid Hepatic Angiomyolipoma and Hepatocellular Carcinoma: Imaging Data From Two Centers
por: Liu, Weihai, et al.
Publicado: (2018)

Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma
por: Yang, Yan, et al.
Publicado: (2021)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma
por: Huang, Xialing, et al.
Publicado: (2019)

Paired assessment of liver telomere lengths in hepatocellular cancer is a reliable predictor of disease persistence
por: Feng, Wendu, et al.
Publicado: (2017)

Preoperative prediction of cytokeratin-19 expression for hepatocellular carcinoma using T1 mapping on gadoxetic acid-enhanced MRI combined with diffusion-weighted imaging and clinical indicators
por: Zhao, Yue, et al.
Publicado: (2023)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

Integration of MRI-Based Radiomics Features, Clinicopathological Characteristics, and Blood Parameters: A Nomogram Model for Predicting Clinical Outcome in Nasopharyngeal Carcinoma
por: Fang, Zeng-Yi, et al.
Publicado: (2022)

Correlation of DCE-MRI Perfusion Parameters and Molecular Biology of Breast Infiltrating Ductal Carcinoma
por: Liu, Li, et al.
Publicado: (2021)

Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
por: Wang, Ruizhi, et al.
Publicado: (2023)

Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
por: Kwok, Christopher, et al.
Publicado: (2023)

Role of Tetraspanins in Hepatocellular Carcinoma
por: Cai, Sicheng, et al.
Publicado: (2021)

Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
por: Li, Binghua, et al.
Publicado: (2018)

Radiomic Feature-Based Predictive Model for Microvascular Invasion in Patients With Hepatocellular Carcinoma
por: He, Mu, et al.
Publicado: (2020)

The value of combined PET/MRI, CT and clinical metabolic parameters in differentiating lung adenocarcinoma from squamous cell carcinoma
por: Tang, Xin, et al.
Publicado: (2022)

A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound LI-RADS Improves Prediction of Microvascular Invasion in Hepatocellular Carcinoma
por: Zhou, Hang, et al.
Publicado: (2021)

Nomogram Based on CT Radiomics Features Combined With Clinical Factors to Predict Ki-67 Expression in Hepatocellular Carcinoma
por: Wu, Cuiyun, et al.
Publicado: (2022)

Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells
por: Piotrowska, Anna, et al.
Publicado: (2021)

Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-World
por: Li, Xiaowei, et al.
Publicado: (2022)

Value of ultrasound combined with MRI in the diagnosis of primary and recurrent hepatocellular carcinoma
por: Ji, Xiaoli, et al.
Publicado: (2019)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

The Different MRI Features of Hepatocellular Adenoma and Hepatocellular Carcinoma
por: Abdullah, Ayoob D, et al.
Publicado: (2023)

Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Multi-Parametric MRI Radiomics
por: Zhang, Yang, et al.
Publicado: (2021)

MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study
por: Yang, Fan, et al.
Publicado: (2021)

Evaluation of Multisource Adaptive MRI Fusion for Gross Tumor Volume Delineation of Hepatocellular Carcinoma
por: Cheung, Andy Lai-Yin, et al.
Publicado: (2022)

Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices
por: Tao, Ziwen, et al.
Publicado: (2021)

Accuracy of Various Forms of Contrast-Enhanced MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhao, Chun, et al.
Publicado: (2021)

Reproducibility for Hepatocellular Carcinoma CT Radiomic Features: Influence of Delineation Variability Based on 3D-CT, 4D-CT and Multiple-Parameter MR Images
por: Duan, Jinghao, et al.
Publicado: (2022)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uc3frrlf10mgrbem9uakos4phi